Zinzino reported its preliminary October 2025 revenue. Compared to October 2024, overall revenue for the company increased 65%, totaling $34 million. Accumulated revenue for year-to-date 2025 improved 55% to $274 million.
Faun Pharma’s external sales did see a 51% decrease in revenue, which offset major gains in certain regions where growth was significant. Central Europe, which includes Austria, Germany and Switzerland, saw a 69% increase in year-to-date revenue. North America, which includes Canada, the US and Mexico, and Asia-Pacific, which includes Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China and the Philippines, reported increases of 183% and 353% respectively.
The post Zinzino Releases Preliminary Sales Report for October 2025 first appeared on Direct Selling News.
